IP Library Granted Patent US 11,324,427
Granted Patent B2
US 11,324,427 · App. 16/391,181 · Granted May 10, 2022

Method and apparatus for measurement of neural response

Inventors: John Louis Parker (Artarmon, AU); Peter Scott Vallack Single (Artarmon, AU); Dean Michael Karantonis (Artarmon, AU)
Assignee: Saluda Medical Pty Ltd
A61B5/24A61B5/4848A61B5/6846A61B5/7285A61M5/1723A61N1/36071A61N1/36125A61N1/36135A61N1/36146A61B5/7203A61M2230/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,324,427
App. No.
16/391,181
Granted
May 10, 2022
Kind
B2
Abstract

A method for measuring a neural response to a stimulus. Measurement circuitry is settled prior to a stimulus, by connecting a sense electrode to the measurement circuitry to allow the measurement circuitry to settle towards a bio-electrically defined steady state. Charge is recovered on stimulus electrodes by short circuiting the stimulus electrodes to each other. An electrical stimulus is then applied from the stimulus electrodes to neural tissue, while keeping the sense electrode disconnected from the measurement circuitry. After the stimulus, a delay is imposed during which the stimulus electrodes are open circuited and the sense electrode is disconnected from the measurement circuitry and from the stimulus electrodes. After the delay, a neural response signal present at the sense electrode is measured by connecting the sense electrode to the measurement circuitry.

Claims (25)

1. A method of measuring a neural response evoked by a stimulus, the method comprising:

applying the stimulus to neural tissue;

during the applying of the stimulus, disconnecting electrode segments of a sense electrode so as to limit disequilibrium arising on the sense electrode to each of the electrode segments; and

measuring a neural response evoked by the stimulus in a neural signal sensed at the sense electrode by connecting the electrode segments to each other, and connecting the sense electrode to measurement circuitry.

2. The method of claim 1 , wherein the measuring a neural response is a single-ended measurement obtained by passing a signal from the sense electrode to a single-ended amplifier.

3. The method of claim 1 , wherein the measuring a neural response is a differential measurement obtained by passing signals from two additional sense electrodes to a differential amplifier, each sense electrode of the two additional sense electrodes comprising at least two respective electrode segments.

4. The method of claim 1 , further comprising obtaining a curve of an averaged measurement vs. stimulus amplitude in order to obtain information regarding recruitment effected by the stimulus.

5. The method of claim 1 , wherein the measuring a neural response is used for feedback control by an implanted neurostimulator.

6. The method of claim 1 , when applied contemporaneously with administration of a drug, in order to gauge efficacy of drug delivery.

7. The method of claim 6 , wherein drug delivery is controlled by feedback based on compound action potential (CAP) measurements.

8. The method of claim 1 , wherein the CAP is recorded within approximately 3 cm of a stimulus site.

9. An implantable device for measuring a neural response evoked by a stimulus, the implantable device comprising:

a plurality of electrodes including one or more stimulus electrodes and one or more sense electrodes, wherein at least one of the one or more sense electrodes comprises at least two sense electrode segments;

one or more stimulus sources for providing the stimulus to be delivered from the one or more stimulus electrodes to neural tissue;

measurement circuitry for amplifying a neural signal sensed at the one or more sense electrodes; and

a control unit configured to:

disconnect the at least two sense electrode segments during delivery of the stimulus, so as to limit disequilibrium arising on the at least one of the one or more sense electrodes to each sense electrode segment of the at least two sense electrode segments;

control the one or more stimulus sources to provide the stimulus to be delivered to the neural tissue;

connect the at least two sense electrode segments to each other and connect the at least one of the one or more sense electrodes to the measurement circuitry; and

measure the neural response evoked by the stimulus in the amplified neural signal.

10. The implantable device of claim 9 ,

wherein at least one of the one or more stimulus electrodes comprises at least two stimulus electrode segments,

wherein the control unit is configured to drive the at least two stimulus electrode segments by distinct respective stimulus sources of the one or more stimulus sources,

wherein the stimulus delivered from the at least one of the one or more stimulus electrode is a sum of contributions of the distinct respective stimulus sources, and

wherein a disequilibrium arising on the at least one of the one or more stimulus electrode during delivery of the stimulus is limited to each stimulus electrode segment of the at least two stimulus electrode segments.

Assignments (4)
SECURITY INTEREST Recorded Mar 14, 2025
From: SALUDA MEDICAL PTY LTD
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 070518/0710 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2020
From: PARKER, JOHN LOUIS; SINGLE, PETER SCOTT VALLACK; KARANTONIS, DEAN MICHAEL
To: SALUDA MEDICAL PTY LTD
Reel/Frame 052956/0970 →
CONFIRMATION OF ASSIGNMENT Recorded Jun 16, 2020
From: NATIONAL ICT AUSTRALIA LTD
To: NICTA IPR PTY LTD
Reel/Frame 052958/0253 →
CONFIRMATION OF ASSIGNMENT Recorded Jun 16, 2020
From: NICTA IPR PTY LTD
To: SALUDA MEDICAL PTY LTD
Reel/Frame 052958/0320 →
Priority Claims (1)
AU 2011901817 · May 13, 2011 · national
Continuity (3)
Continuation 15184787 · Jun 16, 2016
Continuation 14117144
Related Publication 20190307341A1 · Oct 10, 2019